AUG 14, 2026 · PHASE 3 TRIAL
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
ClinicalTrials.gov
This is a registered but actively recruiting Phase 3 trial with no results posted; the design is sound but evidence cannot yet be evaluated.
Reported
Planned enrollment336
PhasePhase 3
Primary outcome measureDisease-free survival, from randomization t…